drugset / Trial / NCT02295150

Prophylaxis of Venous Thromboembolism After Bariatric Surgery

NCT02295150

Phase 4 Unknown 50 enrolled Rijnstate Hospital
NaSingle-groupOpen-labelPrevention

Summary

This study is a prospective evaluation of the relationship between lean body weight and anti-Xa activity and 5700 International Units (IU) nadroparin 4 hours after subcutaneous administration in morbidly obese patients after bariatric surgery.

Timeline

Start
2013-03
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nadroparin Calcium Other / unclassified 5700 iu Subcutaneous